Literature DB >> 8451285

New phthalocyanine photosensitizers for photodynamic therapy.

N L Oleinick1, A R Antunez, M E Clay, B D Rihter, M E Kenney.   

Abstract

Six new aluminum and silicon phthalocyanines have been synthesized and their photocytotoxicity toward V79 cells has been studied. The compounds that have been prepared are: A1PcOSi(CH3)2(CH2)3N(CH3)2, I; A1Pc-OSi(CH3)2(CH2)3N(CH3)3+I-, II; CH3SiPcOSi(CH3)2(CH2)3N(CH3)2, III; HOSiPcOSi(CH3)2(CH2)3N(CH3)2, IV; HOSiPcOSi(CH3)2(CH2)3N(CH3)3+I-, V; and SiPc[OSi(CH3)2(CH2)3N(CH3)3+I-]2, VI. Relative growth delay values for compounds I-VI and relative cytotoxicity values for compounds I, II, IV, V and VI have been determined. Compounds I and II have been shown to be comparable in photocytotoxicity to what is presumed to be A1PcOH.xH2O, and compound IV has been shown to have greater activity. The classes of compounds to which these six compounds belong appear to have potential for photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8451285     DOI: 10.1111/j.1751-1097.1993.tb02282.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  38 in total

1.  Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4.

Authors:  Myriam E Rodriguez; Junhwan Kim; Grace B Delos Santos; Kashif Azizuddin; Jeffrey Berlin; Vernon E Anderson; Malcolm E Kenney; Nancy L Oleinick
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

2.  Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.

Authors:  Alyssa M Master; Megan Livingston; Nancy L Oleinick; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2012-07-19       Impact factor: 4.939

3.  Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy.

Authors:  Hesheng Wang; Baowei Fei
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

4.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

5.  Synthesis, Photophysical and Photochemical Properties of a Set of Silicon Phthalocyanines Bearing Anti-Inflammatory Groups.

Authors:  Belgin Şahin; Sevinc Zehra Topal; Devrim Atilla
Journal:  J Fluoresc       Date:  2016-11-17       Impact factor: 2.217

6.  Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum.

Authors:  Minh Lam; Matthew L Dimaano; Patricia Oyetakin-White; Mauricio A Retuerto; Jyotsna Chandra; Pranab K Mukherjee; Mahmoud A Ghannoum; Kevin D Cooper; Elma D Baron
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

7.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

8.  Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy.

Authors:  Liang-Yan Xue; Song-Mao Chiu; Nancy L Oleinick
Journal:  Autophagy       Date:  2010-03-02       Impact factor: 16.016

9.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

10.  Choline Molecular Imaging with Small-animal PET for Monitoring Tumor Cellular Response to Photodynamic Therapy of Cancer.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Joseph Meyers; Liang-Yan Xue; Gregory Maclennan; Mark Schluchter
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.